Cancer: what's on the cards?
Scientists at Strangeways Research Laboratory are leading the search for the ‘genetic cards’ that determine an individual’s risk of cancer.
Data mining the complex cancer landscape
Computational biology is helping scientists to navigate through the data deluge generated from the analysis of cancer genomes.
Cambridge Cancer Centre: the vision
Professor Sir Bruce Ponder describes the vision of a Cambridge-wide initiative to link world-class cancer research to improved patient care.
Smart testing for smart drugs
Can better decisions be made about which anticancer drugs to progress to clinical trials?
A new model for industrial–academic partnership
PneumaCare, the first company to receive funding from the University of Cambridge Discovery Fund, is a new model for utilising academic expertise.
Strategic research partnership drives materials science research and training
Rolls-Royce and the Engineering and Physical Sciences Research Council will work jointly with the Universities of Cambridge, Birmingham and Swansea in a new £50 million...
Beacons of life and death: chromatin and cancer
A new generation of cancer therapeutics is on the horizon thanks to fresh light being shed on how genes are switched on and off.
Evidence of the first modern humans in North Africa
Excavation of the deepest archaeological trench in North Africa half a century after it was first dug is offering a glimpse of up to 200,000...
Famine’s changing face
Dr Zoltán Tiba’s research on why famines happen is posing questions about the root causes and possible long-term interventions.
The educational neuroscience of dyslexia and dyscalculia
For some children, acquiring the important skills of learning to read or do arithmetic is fraught with difficulty. Educational neuroscience is helping to understand why.